About US
Contact us
>>Back
Bausch + Lomb Introduces New PreserVision® Eye Vitamin
- Publisher：
- Publication：2010/4/12
AREDS 2® Formula Helps Provide Nutritional Support for Patients
Bausch + Lomb announces the U.S. launch of PreserVision® Eye Vitamin and Mineral Supplement AREDS 2 formula. This builds on the original, clinically proven Age-Related Eye Disease Study (AREDS) formula, replacing beta-carotene with lutein (10mg) and zeaxanthin (2mg) and adding omega-3 fatty acids (1000 mg) per daily dosage. The product will be on retail shelves in early May, 2010.
Scientific studies show that the inclusion of high levels of omega-3 fatty acids, lutein and zeaxanthin in the diet supports eye health. Age-related macular degeneration (AMD) is the number one cause of severe vision loss and blindness in the United States for people over the age of 50.
The AREDS2® study, which is currently ongoing and expected to complete in 2013, is sponsored by the National Eye Institute/National Institute of Health and is the second nationwide clinical study to determine whether a combination of vitamins and minerals can further slow the progression of vision loss from AMD. PreserVision AREDS 2 formula is one of many formulas that are being evaluated in this study.
For more information visit: www.bausch.com.
Source: web of APR